FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.

Lizeth Andrea Torres Torres,Gabriel Silva,Jovelina Samara Ferreira Alves,Tatiane Resende Ushida,Julia Potenza,Cristiana Bernadelli Garcia,Lucas Oliveira Sousa,Norberto Peporine Lopes,Luciana Oliveira Almeida,Andréia Machado Leopoldino

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology（2023）

引用 0|浏览6

暂无评分

摘要

FTY720 sensitizes cisplatin-resistant oral squamous cell carcinoma cells for paclitaxel.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要